Dave's transparent fees and robust growth drive its outlook, yet high borrowing costs and valuation risks prompt a cautious ...

It’s one of the most explosive sectors in the market — but also one of the riskiest. Biotech investors, beware. Small-cap biotech stocks can be extremely volatile… but if you know what to look for, ...

The stubbornly strong stock market is giving traders and opportunity to bet against some of the most volatile names.

U.S. stocks rose on news of a U.S.-Japan trade agreement and signs of a potential European Union deal. The key spring-selling season failed to deliver, making a housing-market recovery unlikely this ...

Laurus Labs led the gains in the Nifty Smallcap 100 index, with a rise of over 23% in a month and a 45.3% surge from its ...

Most AI stocks at the moment are at nosebleed valuations. Even the names that once looked reasonable now trade at prices that ...

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Strategy” second quarter 2025 investor ...

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here.

History's answer is strikingly clear: If Palantir follows the historical trend, it may soar in the weeks following its ...

History shows that the golden cross has usually preceded potential further gains or bullish trends in the small-cap benchmark index. Since 1985, the Russell 2000 has, on average, traded higher three ...

The best small-cap ETFs post above-average returns while taking on lower-than-expected risk. Learn about these six top picks ...

President Donald Trump signed into law the One Big Beautiful Bill Act (H.R.1) (OBBBA). This alert focuses on OBBBA changes ...